885520-47-8 Usage
Uses
Used in Pharmaceutical Industry:
1H-Indole, 4-bromo-6-nitrois used as a building block in organic synthesis for the preparation of various pharmaceuticals. Its unique structure and functional groups make it suitable for the development of new drugs with improved therapeutic properties.
Used in Agrochemical Industry:
1H-Indole, 4-bromo-6-nitrois also used as a precursor in the synthesis of agrochemicals. Its chemical properties allow for the creation of compounds with potential applications in pest control and crop protection.
Used in Organic Materials Industry:
1H-Indole, 4-bromo-6-nitrois utilized in the synthesis of various organic materials, such as dyes, pigments, and polymers. Its versatile chemical structure enables the development of new materials with specific properties for different applications.
Used in Medicinal Chemistry Research:
1H-Indole, 4-bromo-6-nitrois studied for its potential biological and pharmacological activities. Researchers explore its interactions with biological targets, such as enzymes and receptors, to understand its therapeutic potential and develop new drugs based on its structure.
Check Digit Verification of cas no
The CAS Registry Mumber 885520-47-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,5,2 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 885520-47:
(8*8)+(7*8)+(6*5)+(5*5)+(4*2)+(3*0)+(2*4)+(1*7)=198
198 % 10 = 8
So 885520-47-8 is a valid CAS Registry Number.
885520-47-8Relevant articles and documents
IMIDAZOLE DERIVATIVES AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS
-
Page/Page column 86-87, (2008/06/13)
In its many embodiments, the present invention provides imidazole derivatives which are inhibitors of alPha2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition or amelioration of one or more conditions associated with the alpha2C adrenergic receptors using such compounds or pharmaceutical compositions. Formula (I).
